Skip to main content

Eli Lilly And Company

Eli Lilly And Company Information



Lilly (Eli) & Co. is an American-based multinational pharma company with offices in 18 countries. Its headquarters are situated in Indianapolis, Indiana, and it sells drugs in over 125 countries. Colonel Eli Lilly was a pharmaceutical chemist and American Civil War veteran who founded this company in 1876. It is traded as LLY in the New York Stock Exchange (NYSE). 

Lilly employs over 33,000 people and generated a revenue of over 22 billion USD as of 2019. The company is committed to researching and developing high-quality drugs for humankind's welfare by remaining true to its work. In 1876, this company produced the medicinal drug called quinine used in the treatment of Malaria. 

Among its many commendable innovations were gelatin-coating for the capsules & pills and sugar-coated pills that make them easier to swallow. It also developed various drugs for treating syphilis, rheumatism, eczema, and psoriasis in the early 1880s. A scientific journal asserted that the Lilly operation was the largest capsule factory in the world in 1917. 

In 1923, Lilly mass-produced the Insulin under the name “Iletin” used to treat diabetes in the US. Moreover, it also became the company to mass-produce Penicillin in the 1940s and started producing the Polio vaccine in the early 1950s. It acquired CoLucid in 20017 for 960mn USD and Armo Biosciences for 1.6bn USD in 2018. 

Also, it purchased the Aurora Kinase A, an inhibitor developer, for 575mn USD. It acquired multiple companies for developing and researching breakthroughs. The company aims to bring life-changing research to the community while performing voluntary & philanthropist operations worldwide. Currently Eli Lilly And Company has a market cap of $561.54 Billion. It has a P.E ratio of 112.57. The shares of Eli Lilly And Company are trading at $591.6.


Organization: Eli Lilly And Company

Employees: 39000

CEO: Mr. David A. Ricks

Industry: Health Technology

Comments

Popular posts from this blog

Ace Your MBA Job Interview: Mastering Placement Season with Confidence!!

Ace Your MBA Job Interview: Mastering Placement Season with Confidence!! Dear Readers, The MBA journey is a rigorous climb, culminating in the crucial placement season. Landing your dream job hinges significantly on how you navigate the job interview.  For MBA students, these interviews are not just Q&A sessions ; they are opportunities to showcase leadership potential, strategic thinking, and the value you bring to an organization.  This article, inspired by common interview questions, will equip you with the insights to confidently navigate your MBA job interviews and secure your desired placement. 1) Crafting Your Narrative: "Tell Me About Yourself" This seemingly simple question is your opening act. Instead of reciting your resume, tell a compelling story. MBA students should weave together their academic journey, professional experiences, and career aspirations into a narrative that highlights their growth and trajectory. Explain what sparked your initial interest ...

DeepSeek’s Disruption: Redefining the AI Landscape is a Game changer for China & the World!!

DeepSeek’s Disruption: Redefining the AI Landscape The AI industry is undergoing a seismic shift, and at the center of this transformation is DeepSeek, a trailblazing innovator challenging the status quo. While established players like OpenAI and Anthropic have dominated the field with massive investments in compute power, DeepSeek has emerged with a groundbreaking approach that is not only more efficient but also significantly more cost-effective. This disruption has the potential to reshape the AI ecosystem, democratize access to advanced AI capabilities, and even threaten the dominance of hardware giants like Nvidia. The Current Landscape: A High-Cost Game Training state-of-the-art AI models today is an exorbitantly expensive endeavor. Leading AI companies spend upwards of $100 million on compute resources alone, relying on massive data centers equipped with thousands of high-end GPUs, each costing around $40,000. This paradigm has created a high barrier to entry, limiting AI develo...

Futures and Options Trading: The Gamble of Tomorrow

Futures and Options Trading: The Gamble of Tomorrow Rajiv leaned back in his chair, eyes glued to the screen showing live market data. Numbers flickered as if teasing him, reflecting both opportunity and risk. He had been trading futures and options for a few years, with moderate success, but today he was feeling ambitious. Nifty was trading near an all-time high, and analysts were split on where it would go next. He believed he saw an opportunity - one that could make him more in a month than he’d made all year. Or… it could leave him in debt. But that was the allure of the market. He took a deep breath and logged into his brokerage account, skimming through the available contracts. A recent rally had pushed Nifty up to 24,550, and Rajiv was betting that it had more room to grow before month’s end. But he wasn’t interested in buying stocks outright. Futures and options trading - derivatives - was where he found his thrill. For weeks, he’d analyzed historical price movements, read econ...